配套完培,省时省力,单买细胞无优惠
产品名称 |
Nthy-ori 3-1人甲状腺正常细胞 |
货号 |
ZQ0874 |
产品介绍 |
Nthy-ori 3-1是一种人甲状腺正常细胞系,是通过将含有起源缺陷的Simian virus 40 (SV40) 基因组(SV-ori)质粒转染至正常的人类甲状腺滤泡上皮细胞中实现永生化的。该细胞保留了正常甲状腺细胞的多种功能,是研究甲状腺功能和相关疾病的重要工具。 |
种属 |
人 |
性别/年龄 |
女性/35岁 |
组织 |
甲状腺 |
疾病 |
常态 |
细胞类型 |
转化细胞系 |
形态学 |
上皮的 |
生长方式 |
贴壁 |
倍增时间 |
大约24~48小时。 另:文献《Mechanisms of three-dimensional growth of thyroid cells during long-term simulated microgravity》中提到,Nthy-ori 3-1细胞在模拟微重力条件下培养7天和14天后,观察到了多细胞球体(MCS)的形成。这表明在实验条件下,细胞在这段时间内经历了至少一次传代。 |
培养基和添加剂 |
1640基础培养基(中乔新舟 货号:ZQ-200)+10%FBS(中乔新舟 货号:ZQ500-A)+1%PS(中乔新舟 货号:CSP006) |
推荐完全培养基货号 |
|
生物安全等级 |
BSL-1 |
STR位点信息 |
Amelogenin: X |
培养条件 |
95%空气,5%二氧化碳;37℃ |
抗原表达/受体表达 |
*** |
基因表达 |
*** |
保藏机构 |
ECACC; 90011609 |
供应限制 |
仅供科研使用 |
货号 |
ZQ0874 |
发货规格 |
活细胞:T25培养瓶*1瓶或者1ml 冻存管*1支(细胞量约为5 x 10^5 cells/vial)二选一 |
发货形式 |
活细胞:常温运输;冻存管:干冰运输 |
储存温度 |
活细胞:培养箱;冻存管:液氮罐 |
产地 |
中国 |
供应限制 |
仅供科研使用 |
论文标题: Thyroid stimulating hormone aggravates diabetic retinopathy through the mitochondrial apoptotic pathway
DOI: 10.1002/jcp.30563
发表时间: 2021-08-25
期刊: JOURNAL OF CELLULAR PHYSIOLOGY
影响因子: 6.384
货号: ZQ0874
产品名称: Nthy-ori 3-1 cells
原文链接: https://onlinelibrary.wiley.com/doi/abs/10.1002/jcp.30563
论文标题: Transcriptional Expressions of ALDH1A1/B1 as Independent Indicators for the Survival of Thyroid Cancer Patients.
DOI: 10.3389/fonc.2022.821958
发表时间: 2022-02-23
期刊: Frontiers in Oncology
影响因子: 6.244
货号: ZQ0874
产品名称: Thyroid epithelial cell line nthy-ori 3-1
原文链接: https://europepmc.org/article/pmc/pmc8905520?javascript_support=no论文标题: Systematic Analysis of Survival-Associated Alternative Splicing Signatures in Thyroid Carcinoma
DOI: 10.3389/fonc.2021.561457
发表时间: 2021-06-23
期刊: Frontiers in Oncology
影响因子: 6.244
货号: ZQ0874
产品名称: Nthy-ori 3-1 cells
原文链接: https://www.frontiersin.org/articles/10.3389/fonc.2021.561457/full?utm_source=S-TWT&utm_medium=SNET&utm_campaign=ECO_FONC_XXXXXXXX_auto-dlvrit
论文标题: miR-30b-5p inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting GALNT7 via the EGFR/PI3K/AKT pathway
DOI: 10.1186/s12935-021-02323-x
发表时间: 2021-11-24
期刊: Cancer Cell International
影响因子: 5.722
货号: ZQ0874
产品名称: Nthy-ori-3-1 cells
原文链接: https://cancerci.biomedcentral.com/articles/10.1186/s12935-021-02323-x
论文标题: Tripartite motif containing 63, regulated by E26 transformation specific variant 4, facilitates the thyroid carcinoma progression and the AKT, p38, and ERK signaling pathways
DOI: 10.1016/j.mce.2022.111639
发表时间: 2022-04-04
期刊: MOLECULAR AND CELLULAR ENDOCRINOLOGY
影响因子: 4.102
货号: ZQ0874
产品名称: Nthy-ori 3-1 cells
原文链接: https://www.sciencedirect.com/science/article/pii/S0303720722000879
论文标题: Circular RNA hsa_circ_0001666 sponges miR‑330‑5p, miR‑193a‑5p and miR‑326, and promotes papillary thyroid carcinoma progression via upregulation of ETV4
DOI: 10.3892/or.2021.8001
发表时间: 2021-03-03
期刊: ONCOLOGY REPORTS
影响因子: 3.906
货号: ZQ0874
产品名称: Nthy-ori 3-1 cells
原文链接: https://www.spandidos-publications.com/10.3892/or.2021.8001
论文标题: miR-744–5p mediates lncRNA HOTTIP to regulate the proliferation and apoptosis of papillary thyroid carcinoma cells
DOI: 10.1016/j.yexcr.2020.112024
发表时间: 2020-04-23
期刊: EXPERIMENTAL CELL RESEARCH
影响因子: 3.383
货号: ZQ0874
产品名称: Nthy-ori-3-1 cell line
原文链接: https://www.sciencedirect.com/science/article/pii/S0014482720302500
PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458
Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.
A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.
Cancer Res. 70:2158-2164(2010)
PubMed=21868764; DOI=10.1158/1078-0432.CCR-11-0690
Zhao M., Sano D., Pickering C.R., Jasser S.A., Henderson Y.C., Clayman G.L., Sturgis E.M., Ow T.J., Lotan R., Carey T.E., Sacks P.G., Grandis J.R., Sidransky D., Heldin N.-E., Myers J.N.
Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites.
Clin. Cancer Res. 17:7248-7264(2011)
PubMed=22087789; DOI=10.1186/1755-8166-4-26
Maric I., Viaggi S., Caria P., Frau D.V., Degan P., Vanni R.
Centrosomal and mitotic abnormalities in cell lines derived from papillary thyroid cancer harboring specific gene alterations.
Mol. Cytogenet. 4:26.1-26.8(2011)
PubMed=30737244; DOI=10.1158/1078-0432.CCR-18-2953
Landa I., Pozdeyev N., Korch C.T., Marlow L.A., Smallridge R.C., Copland J.A. III, Henderson Y.C., Lai S.Y., Clayman G.L., Onoda N., Tan A.-C., Garcia-Rendueles M.E.R., Knauf J.A., Haugen B.R., Fagin J.A., Schweppe R.E.
Comprehensive genetic characterization of human thyroid cancer cell lines: a validated panel for preclinical studies.
Clin. Cancer Res. 25:3141-3151(2019)
货号 | 产品名称 | 规格 | 价格 | 指令 |